Cutaneous Rosai‐Dorfman Disease With MAP2K1 Mutation Treated With Encorafenib and Binimetinib

JEADV Clinical Practice · Published 2026-07-04 · DOI 10.1002/jvc2.70396

Free full text

Authors (3)

Melike Ak, Reinhard Dummer, Egle Ramelyte

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ak, M., Dummer, R., Ramelyte, E. (2026). Cutaneous Rosai‐Dorfman Disease With MAP2K1 Mutation Treated With Encorafenib and Binimetinib. JEADV Clinical Practice. https://doi.org/10.1002/jvc2.70396

Related articles

• Shady Dealings: A Qualitative Review of Internet‐Based Sunglasses‐Related Misinformation · JEADV Clinical Practice · 2026 · Same journal
• A Useful Technique for a Stable and Compressive Dressing After Linear Scalp Sutures: The “Candy Dressing” · JEADV Clinical Practice · 2026 · Same journal
• Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions · JEADV Clinical Practice · 2026 · Same journal
• Redefining Acne as a Distinct Inflammatory Disease: Acne Is Not an Aesthetic Issue · JEADV Clinical Practice · 2026 · Same journal
• Stochastic Instability of Multimodal Large Language Models in Dermoscopic Triage: A Reproducibility Study · JEADV Clinical Practice · 2026 · Same journal
• Nail Lichen Planus in Children ‐ Epidemiology, Pathogenesis, Clinical Presentation, and Treatment · JEADV Clinical Practice · 2026 · Same journal
• Pink Polypoid Papulo‐Vesicles on Labia Majora · JEADV Clinical Practice · 2026 · Same journal
• Residual Limb Hyperhidrosis in Prosthetic Users: First Prospective Pilot of Topical Antiperspirant Treatment · JEADV Clinical Practice · 2026 · Same journal
• Editor's Picks June 2026 · JEADV Clinical Practice · 2026 · Same journal
• Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center · JEADV Clinical Practice · 2026 · Same journal